Gilead Sciences Stock Drops After Goldman Says "Sell"

GILD stock has been choppy on the charts in recent months

May 28, 2019 at 9:27 AM
facebook twitter linkedin


Goldman Sachs downgraded Gilead Sciences, Inc. (NASDAQ:GILD) to "sell" from "neutral," and slashed its price target by $10 to $60 -- a discount to last Friday's close at $66.89. The brokerage firm said it sees short-term deceleration in the drugmaker's top-line growth, and said it will likely take time for GILD's new CEO to rebuild the company's pipeline.

In reaction, GILD stock is down 2.4% ahead of the bell. It's been a choppy stretch for the shares since skimming a five-year low near the round $60 mark in late December. While the equity rallied all the way back up to $70 by Feb. 1, it's since been stuck beneath a trendline connecting lower highs, though the $62 level has served as a steady floor in recent months.

Sentiment around Wall Street remains upbeat. While the majority of the 20 analysts in coverage still maintain a "strong buy" rating on GILD shares, a slim 1% of its float is dedicated to short interest.

Meanwhile, in the options pits, the June 65 put is home to peak front-month open interest of almost 10,400 contracts. Data from the major options exchanges confirms significant sell-to-open activity here, meaning put writers expect $65 to serve as a short-term floor for Gilead Sciences stock through June options expiration.

 

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners